BIOMAT Database Logo BIOMAT Database Logo

Effect of somatostatin on plasma prolactin. 1985

R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi

UI MeSH Term Description Entries
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Effect of somatostatin on plasma renin activity.
June 1979, Endocrinologia japonica,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Effect of oral cimetidine on plasma prolactin.
December 1981, Israel journal of medical sciences,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Effect of piperoxane on rat plasma prolactin.
January 1978, Communications in psychopharmacology,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Remoxipride: pharmacokinetics and effect on plasma prolactin.
September 1991, British journal of clinical pharmacology,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin.
November 1978, Diabetologia,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Somatostatin: its influence on plasma levels of growth hormone, prolactin and thyrotropin in sheep.
May 1975, Journal of animal science,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Baclofen: lack of effect on human plasma prolactin.
January 1978, Communications in psychopharmacology,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Effect of quipazine on rat plasma prolactin levels.
October 1976, Life sciences,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
Effect of prolactin on plasma DHEA (s) levels.
June 1977, The Journal of clinical endocrinology and metabolism,
R Lugari, and P Dall'Argine, and V Nicolotti, and A Parmeggiani, and B Dall'Aglio, and A Gnudi
The effect of bright light on plasma prolactin.
November 1988, Biological psychiatry,
Copied contents to your clipboard!